News
HealthDay on MSN18m
Adding Bevacizumab to Chemo Beneficial in High-Risk Ovarian CancerThe addition of bevacizumab to first-line (1L) chemotherapy offers real-world benefit to patients with epithelial ovarian ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback